Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
It requires a professional blood draw (venous sample) to ensure the highest level of detail
Arch Neurol
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
At OC Wellness, we prescribe the No DAC (Drug Affinity Complex) formulation of CJC-1295 also known as Modified GRF (1-29)
US$ 26.58
US$ 21.23
US$ 29.54
US$ 22.92
